I

Intermountain Ventures

16 employees

Intermountain Ventures is the strategic investment arm of Intermountain Healthcare.

Investor insights

Sectors invested in

Health Care10
Medical Device3
Biotechnology3
Big Data3
Information Technology3
Wellness3
care management2
InsurTech2
Database2
Health Diagnostics2
Artificial Intelligence2
Software2
Therapeutics2
Medical2
Digital Health2
IBS2
employee wellness2
Chronic Illness2
digestive diseases2
personalized healthcare2

Funding rounds participated in

$30M sweet spot round size

Most of their 11 investments are in rounds between $16M and $81M

Basic info

Industry

venture capital and private equity principals

Sectors

Financial Services
Finance
Venture Capital

Date founded

2019

Investments made

V

Vivante Health raised $31M on September 20, 2023

Investors: Distributed Ventures, 7wire Ventures, SemperVirens Venture Capital, Health Catalyst Capital Management LLC, Mercato Partners and Intermountain Ventures

O

Octave Bioscience raised $30M on July 26, 2023

Investors: Section 32, Northpond Ventures, Hikma Ventures, Casdin Capital, LLC, ECHO and Intermountain Ventures

A

Axuall raised $20M on May 31, 2023

Investors: Epsilon Health Investors, LLC, JumpStart Ventures, Flare Capital Partners, M25 and Intermountain Ventures

M

Maven Clinic raised $90M on November 14, 2022

Investors: La Famiglia VC, JAFCO Ventures, Dragoneer Investment Group, Lux Capital, Oak HC/FT, General Catalyst and Intermountain Ventures

V

Vivante Health raised $16M on March 8, 2022

Investors: Big Pi Ventures, FCA Venture Partners, 7wire Ventures, Lifeforce Capital, SemperVirens Venture Capital, Leaps by Bayer and Intermountain Ventures

A

Axuall raised $10M on July 1, 2021

Investors: M5 Venture, University Hospitals Ventures, JumpStart Inc., AV8 Ventures, Epsilon Health, Flare Capital Partners and Intermountain Ventures

S

SomaLogic raised $81M on December 23, 2020

Investors: NECソリューションイノベータ(株), Logos Global Management, LP, Revelation Partners, Boston Millennia Partners, Millennium Partners, Redmile Group and Intermountain Ventures

R

Recursion Pharmaceuticals raised $239M on September 9, 2020

Investors: Laurion Capital Management LP, Two Sigma Ventures, Obvious Ventures, Samsara BioCapital, Felicis Ventures, Lux Capital, Leaps by Bayer and Intermountain Ventures

G

GYANT.com, Inc. raised $14M on July 15, 2020

Investors: Grazia Equity, Alpana Ventures SA and Intermountain Ventures

S

Syapse raised $30M on May 28, 2020

Investors: Revelation Partners, Safeguard Scientifics, Ascension Ventures and Intermountain Ventures

FAQ